Dr. Julia Appelskog is the QPPV at Bluefish Pharmaceuticals. She is an active member of PV Committee of Medicines for Europe and the Chairman of PV working Group at Swedish Generic Medicines Association (FGL). Her expertise spans the entire product life cycle and covers medicinal products (Rx, OTC, generic and vaccines), medical device and cosmetics. Julia has more than 14 years of experience in Pharmacovigilance and held leading pharmacovigilance positions in large pharma companies, such as MSD, Johnson & Johnson and Sanofi Pasteur MSD. Since 2006, she has been given several presentations within pharmacovigilance field.